AU2003287965A8 - Modulation of peroxisome proliferator activated receptors activity - Google Patents
Modulation of peroxisome proliferator activated receptors activityInfo
- Publication number
- AU2003287965A8 AU2003287965A8 AU2003287965A AU2003287965A AU2003287965A8 AU 2003287965 A8 AU2003287965 A8 AU 2003287965A8 AU 2003287965 A AU2003287965 A AU 2003287965A AU 2003287965 A AU2003287965 A AU 2003287965A AU 2003287965 A8 AU2003287965 A8 AU 2003287965A8
- Authority
- AU
- Australia
- Prior art keywords
- modulation
- peroxisome proliferator
- activated receptors
- proliferator activated
- receptors activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02360298 | 2002-10-24 | ||
| EP02360298.0 | 2002-10-24 | ||
| EP02360372 | 2002-12-20 | ||
| EP02360373.1 | 2002-12-20 | ||
| EP02360373 | 2002-12-20 | ||
| EP02360372.3 | 2002-12-20 | ||
| US45695403P | 2003-03-25 | 2003-03-25 | |
| US60/456,954 | 2003-03-25 | ||
| EP03360070 | 2003-06-11 | ||
| EP03360070.1 | 2003-06-11 | ||
| EP03360091.7 | 2003-07-24 | ||
| EP03360091 | 2003-07-24 | ||
| PCT/EP2003/011710 WO2004037248A2 (en) | 2002-10-24 | 2003-10-22 | Modulation of peroxisome proliferator activated receptors activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003287965A8 true AU2003287965A8 (en) | 2004-05-13 |
| AU2003287965A1 AU2003287965A1 (en) | 2004-05-13 |
Family
ID=32180796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003287965A Abandoned AU2003287965A1 (en) | 2002-10-24 | 2003-10-22 | Modulation of peroxisome proliferator activated receptors activity |
| AU2003282051A Abandoned AU2003282051A1 (en) | 2002-10-24 | 2003-10-24 | Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003282051A Abandoned AU2003282051A1 (en) | 2002-10-24 | 2003-10-24 | Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
Country Status (2)
| Country | Link |
|---|---|
| AU (2) | AU2003287965A1 (en) |
| WO (2) | WO2004037248A2 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10315573A1 (en) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituted pyrazoles |
| DE10315569A1 (en) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Substituted pyrazole compounds |
| DE10315571A1 (en) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | pyrazole |
| PE20050226A1 (en) * | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | ARIL-HETEROAROMATIC PRODUCTS AND COMPOSITIONS CONTAINING THEM |
| WO2005061462A2 (en) * | 2003-12-19 | 2005-07-07 | Neurogen Corporation | Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators |
| EP1735284A1 (en) | 2004-03-18 | 2006-12-27 | Pfizer Limited | N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
| US20060252670A1 (en) * | 2004-10-14 | 2006-11-09 | Intercept Pharmaceuticals Inc. | Method of reducing drug-induced adverse side effects in a patient |
| CA2613522A1 (en) * | 2005-06-27 | 2007-01-04 | Exelixis, Inc. | Imidazole based lxr modulators |
| US8097610B2 (en) * | 2005-08-26 | 2012-01-17 | Shionogi & Co., Ltd. | Derivative having PPAR agonistic activity |
| WO2007052843A1 (en) * | 2005-11-04 | 2007-05-10 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
| WO2007122970A1 (en) * | 2006-04-20 | 2007-11-01 | Osaka University | Ligand capable of binding to nuclear receptor |
| US9315449B2 (en) | 2008-05-15 | 2016-04-19 | Duke University | Substituted pyrazoles as heat shock transcription factor activators |
| US8633252B2 (en) * | 2009-01-26 | 2014-01-21 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
| EP2410858B1 (en) * | 2009-03-23 | 2016-09-07 | Merck Sharp & Dohme Corp. | P2x3 receptor antagonists for treatment of pain |
| AR076984A1 (en) * | 2009-06-08 | 2011-07-20 | Merck Serono Sa | DERIVATIVES OF PIRAZOL OXADIAZOL |
| MX350442B (en) * | 2011-07-29 | 2017-09-06 | Karyopharm Therapeutics Inc | Nuclear transport modulators and uses thereof. |
| EP3333164B1 (en) | 2011-07-29 | 2023-06-07 | Karyopharm Therapeutics Inc. | Hydrazide containing nuclear transport modulators and uses thereof |
| TW201321367A (en) * | 2011-10-25 | 2013-06-01 | Du Pont | 1,3-diaryl-substituted heterocyclic pesticides |
| CN103254133A (en) * | 2012-02-20 | 2013-08-21 | 南京大学 | Preparation method of diarylpyrazolylaniline compounds, and application of compounds in colorectal cancer treatment |
| RS60424B1 (en) | 2012-05-09 | 2020-07-31 | Biogen Ma Inc | Nuclear transport modulators and uses thereof |
| US10202366B2 (en) | 2013-03-15 | 2019-02-12 | Karyopharm Therapeutics Inc. | Methods of promoting wound healing using CRM1 inhibitors |
| BR112015032071B1 (en) | 2013-06-21 | 2022-06-14 | Karyopharm Therapeutics Inc | NUCLEAR TRANSPORT MODULARS AND THEIR USES |
| DK3180331T3 (en) | 2014-08-15 | 2022-09-12 | Karyopharm Therapeutics Inc | POLYMORPHS OF SELINEXOR |
| EP3286181B1 (en) * | 2015-04-22 | 2021-01-27 | Rigel Pharmaceuticals, Inc. | Pyrazole compounds and method for making and using the compounds |
| WO2016202935A1 (en) | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| MA43530A (en) | 2015-12-31 | 2018-11-07 | Karyopharm Therapeutics Inc | NUCLEAR TRANSPORT MODULATORS AND THEIR USES |
| WO2017117529A1 (en) | 2015-12-31 | 2017-07-06 | Karyopharm Therapeutics Inc. | Nuclear transport modulators and uses thereof |
| KR101857714B1 (en) * | 2016-02-05 | 2018-05-15 | 연세대학교 산학협력단 | Novel amide compounds and use thereof |
| WO2018098472A1 (en) | 2016-11-28 | 2018-05-31 | Karyopharm Therapeutics Inc. | Crm1 inhibitors for treating epilepsy |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| AR119857A1 (en) | 2019-08-30 | 2022-01-19 | Rigel Pharmaceuticals Inc | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF AND THEIR USE FOR THE INHIBITION OF AN IRAQ PROTEIN |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATA210876A (en) * | 1975-03-25 | 1979-01-15 | Byk Gulden Lomberg Chem Fab | PROCESS FOR THE PRODUCTION OF NEW NIDROFURYL PYRAZOLE DERIVATIVES |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| AU759255B2 (en) * | 1998-01-29 | 2003-04-10 | Amgen, Inc. | PPAR-gamma modulators |
| GB9824614D0 (en) * | 1998-11-11 | 1999-01-06 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-10-22 WO PCT/EP2003/011710 patent/WO2004037248A2/en not_active Application Discontinuation
- 2003-10-22 AU AU2003287965A patent/AU2003287965A1/en not_active Abandoned
- 2003-10-24 AU AU2003282051A patent/AU2003282051A1/en not_active Abandoned
- 2003-10-24 WO PCT/EP2003/011855 patent/WO2004043951A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004043951A1 (en) | 2004-05-27 |
| WO2004037248A2 (en) | 2004-05-06 |
| AU2003287965A1 (en) | 2004-05-13 |
| WO2004037248A3 (en) | 2004-06-03 |
| AU2003282051A1 (en) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003287965A8 (en) | Modulation of peroxisome proliferator activated receptors activity | |
| IL158873A0 (en) | Modulators of peroxisome proliferator activated receptors | |
| HK1078007A1 (en) | Pramipexole once-daily dosage form | |
| HUP0304051A3 (en) | Furan and thiophene derivatives activating the human peroxisome proliferator activated receptors | |
| AU2003286263A8 (en) | Complexes of receptors | |
| EP1572113A4 (en) | Calcium receptor modulating compound and use thereof | |
| IL166334A0 (en) | Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity | |
| IL163768A0 (en) | Thiazole and oxazole derivatives that modulate ppar activity | |
| HUS2200036I1 (en) | Use of dihydroimidazolones for the treatment of dogs | |
| AU2003217974A1 (en) | Hoofed animal pad | |
| AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| EP1567182A4 (en) | Preventing desensitization of receptors | |
| GB2406087B (en) | Fluid applicator | |
| GB0225580D0 (en) | Disposable toothbrush | |
| IL169110A0 (en) | Modulation of peroxisome proliferator-activated receptors | |
| AU2003295790A8 (en) | Modulation of iap-like expression | |
| IL165942A0 (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of vib or both vib and via receptors | |
| AU2003290763A8 (en) | Modulation of jumonji expression | |
| AU149727S (en) | Fluid applicator | |
| AU2003246861A1 (en) | Use of agents that modulate pde11a activity | |
| AU2003296499A8 (en) | Modulation of ppar-alpha expression | |
| AU2003295793A8 (en) | Modulation of ku86 expression | |
| GB0200202D0 (en) | Sanitary pad | |
| GB0207412D0 (en) | Rhodanine compounds and their therapeutic use | |
| EP1579866A4 (en) | Novel use of edg receptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |